Chimeric Therapeutics is trading 16.67% up at A$0.01 after rising from the prior A$0.01 close, apparently driven by low-priced-stock trading activity or market noise.
- No clear company-specific announcement dated September 21, 2026 explains the move; available ASX coverage runs through September 18.
- Recent reported items concern earlier capital and clinical updates.
- Major indices were essentially flat, with no strong sector catalyst identified; confidence in the explanation is low.